Early prediction of treatment outcome in head and neck cancer with 2- 18FDG PET

Acta Oncologica

Volumn 36, Issue 7, 1997, Pages 741-747

  Brun, Eva ^a   Ohlsson, Tomas ^a   Erlandsson, Kjell ^a   Kjellén, Elisabeth ^a   Sandell, Anders ^a   Tennvall, Jan ^a   Wennerberg, Johan ^a   Strand, Sven Erik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; IRIDIUM;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GLUCOSE METABOLISM; HEAD AND NECK CANCER; HUMAN; ISOTOPE LABELING; MALE; METABOLIC RATE; NECK DISSECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031408018     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869709001348     Document Type: Article

References (26)

1. TNN Classification of Malignant Tumours. UICC, 1992. Springer Verlag. ISBN 0-387-17366-8.
2. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-14.
3. Mathupala SP, Rempel A, Pedersen PL. Glucose catabolism in cancer cells. Isolation, sequence and activity of the promoter for type II hexokinase. J Biol Chem 1995; 28: 16918-25.
4. Minn H, Lapela M, Klemi P, et al. Positron emission tomography in prediction of survival in head and neck cancer. In: Studies on clinical applications of positron emission tomography in oncology (dissertation). Turku: University of Turku, Finland, 1996.
5. Nieweg O, Pruim J, van Ginkel J, et al. Fluorine-18-fluordeoxglucose PET imaging of soft-tissue sarcoma. J Nucl Med 1996; 37: 257-61.
6. Flier JS, Mueckler MM, Usher P, Lodish HF. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 1987; 235: 1492-5.
7. Brown RS, Wahl RL. Overexpression of Glut-1 glucose transporter in human breast cancer. Cancer 1993; 72: 2979-85.
8. Persons DA, Schek N, Hall BL, Finn OJ. Increased expression of glycolysis-associated genes in oncogene-transformed and growth-accelerated states. Mol Carcinogenesis 1989; 2: 88-94.
9. Andrich MP, Neumann R. The role of positron emission tomography imaging in early assessment of the antitumour impact of biologics and cytotoxics. Our Opinion in Oncol 1994; 6: 627-32.
10. Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R. Metabolic monitoring of breast cancer, chemo-hormonotherapy, using positron emission tomography, an initial evaluation. J Clin Oncol 1993; 11: 2101-11.
11. 18FDG production with a low energy electrostatic proton accelerator and a dual headed PET scanner. Acta Oncol 1992; 31: 771-6.
12. Erlandsson K, Strand S-E. A new approach to three-dimensional image reconstruction in PET. IEEE Trans Nucl Sci 1992; 39: 1438-43.
13. 18O target. Nuclear Instruments and Methods in Physics Research 1996; 379: 341-2.
14. 18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary ammonium resin. Nucl Med Biol 1990; 17: 273-9.
15. Rhodes CG, Wise RJS, Gibbs JM, et al. In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas. Ann Neurol 1983; 14: 614-26.
16. Sokoloff L, Reivieh M, Kennedy C, et al. The [14C]-deoxyglucose method for the measurement of local cerebral glucose utilization. Theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977; 28: 897-916.
17. Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med 1988; 29: 1521-5.
18. Chaiken L, Rege S, Hoh C, et al. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy. Int J Radiat Oncol Biol Phys 1993; 27: 455-64.
19. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972-80.
20. Strauss LG, Clorius JH, Schlag P, et al. Recurrence of colorectal tumors: PET evaluation. Radiology 1989; 170: 329-32.
21. Reisser C, Haberkorn U, Dimitrakopoulou A, Strauss A, Seifert E, Strauss LG. Chemotherapeutic management of head and neck malignancies with positron emission tomography. Arch Otolaryngol Head and Neck Surg 1995; 121: 272-6.
22. Seifert E, Schadel A, Haberkorn U, Strauss LG. Evaluating the effectiveness of chemotherapy in patients with head and neck tumours using positron emission tomography. HNO 1992; 40: 90-3.
23. Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med 1993; 34: 12-17.
24. Kapoor RR, Spence AM, Muzi M, Graham MM, Abott GL, Krohn KA. Determination of the deoxyglucose and glucose phosphorylation ratio and the lumped constant in rat brain and a transplantable rat glioma. J Neurochem 1989; 53: 37-44.
25. Kato A, Diksie M, Yamamoto YL, Feindel W. Quantification of glucose utilization in an experimental brain tumor model by the deoxyglucose method. J Cereb Blood Flow Metab 1985; 5: 108-14.
26. Langen KJ, Braun U, Rota Kops E, et al. The influence of plasma glueose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med 1993; 34: 355-9.